June 23, 2009 (Toronto, Ontario) — Data from a preclinical study presented here at the Society of Nuclear Medicine 56th Annual Meeting suggest that alpha-therapy, in association with fast-clearing ...
In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...
Alpha DaRT alpha-particle therapy, key 2026 trial catalysts, cash/dilution risks, and M&A takeover potential. See more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results